MARATTO

preprint · SSRN Electronic Journal

Nano-Reprogrammed Pitavastatin Cubosomes for Hepatocellular Carcinoma: Boosted Cytotoxicity, In Vivo Pharmacokinetics, and Multitarget Anticancer Action

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Nanoparticle-Based Drug Delivery
  • Cancer, Lipids, and Metabolism
  • Lipid Membrane Structure and Behavior

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2139/ssrn.6250088

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.